The best TED Talk's nudge you out of your comfort zone, flip the lights on in shadowy corners of your understanding, and ...
Company reported positive phase 3 THRIVE-2 study results using veligrotug in treating chronic thyroid eye disease patients, positioning it to file a BLA in the 2nd half 2025. The company is developing ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈